NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
3SIXTY PHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097869217Class
35, 41, 42, 45
Filing
97869217
Registration
8055180
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
12/09/2025
Trademark type
Combined
Nice classes
35, 41, 42, 45
Filing date
04/02/2023
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2018
First use in commerce
01/01/2018
Drawing code
3
Owner type
16
Owner location
Conshohocken, PA, US
Examiner
ORSCHELN, COLLEEN J
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
3Sixty Pharma Solutions LLC.
Representatives
3Sixty Pharma Solutions LLC.
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Regulatory submission management in the field of medical researchclinical and non-clinical studiesassisting others in preparing and filing applications for new drugs with governmental regulatory bodies
Class 41
Development of printed educational materials of others in the field of life sciences and scientific research information to share with physicians and other health care professionalspatientsmedicalpharmaceutical and biotechnology companies
Class 42
Consulting services for others in the field of designplanningimplementation project management of medicalscientific and data analysis research services for others; Scientific research in the nature of conducting and analyzing clinical trials for others in the pharmaceuticalbiotechnologymedical devicelife sciences fields; pharmaceutical drug evaluationresearchdevelopment services; biotechnology product evaluationresearchdevelopment services; medical device evaluationresearchdevelopment services; life science technology evaluationresearchdevelopment servicesdeveloping clinical and pre-clinical trial designs and methodologies; consulting services in the area of pharmaceuticalbiotechnologymedical device clinical testing; extended clinical research services for othersoversight of computerized data management of clinical trialsbiostatistical analysis; preclinical research and development planningevaluationexecution; repairing flawed clinical trials and dossiersstrategic clinical research portfolio managementoversight of biosurveillance monitoring; providing regulatory-compliant technical writing in the field of medical researchclinical and non-clinical studies; consulting services in the field of contract clinical researchcontract product development; Internet developmentdesign and consulting services for otherscreating websites featuring blogs about medical and pharmaceutical information related to therapeutics and illnesses and disease
Class 45
Regulatory compliance consulting in the field of clinical research and medical product development
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/21/2025
PUBO
PUBLISHED FOR OPPOSITION
10/21/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/15/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/25/2025
GNRT
NON-FINAL ACTION E-MAILED
04/25/2025
CNRT
NON-FINAL ACTION WRITTEN
04/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2025
ALIE
ASSIGNED TO LIE
08/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/23/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/16/2024
GNRT
NON-FINAL ACTION E-MAILED
01/16/2024
CNRT
NON-FINAL ACTION WRITTEN
01/16/2024
DOCK
ASSIGNED TO EXAMINER
12/28/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2023
NWAP
NEW APPLICATION ENTERED
04/05/2023
Continuous trademark protection
Get notified about every new filing that threatens 3SIXTY PHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.